JUN 16, 2017 6:07 AM PDT

Vitamin C & Antibiotics: A Potent Duo Against Cancer?

WRITTEN BY: Xuan Pham

Over the years, vitamin C has become synonymous with health, vigor, and vitality. Now the compound, in combination with an antibiotic, has been shown to be effective at killing cancer stem cells. The discovery shines a new light on vitamin C and its cancer-killing potential.

Image credit: Pixabay.com

Vitamin C has a long record with the medical community. In 1753, the compound was shown to ward off scurvy – a condition that was common among sailors at the time. Since then, vitamin C was purported to be effective against viruses like the common cold and the flu. Moreover, this compound has also been explored as an anticancer agent for several types of cancer, including colon cancer and leukemia.

But targeting cancer stem cells with vitamin C has never been attempted before. Similar to healthy stem cells, cancer stem cells  have the capacity to self-renew and differentiate into many other cell types. In the case of cancer stem cells, however, the result could be new tumor formation, metastasis, and drug resistance. "Therefore, new therapeutic strategies are necessary to identify and eradicate CSCs," the authors wrote in their study, published in the journal Oncotarget.

In the current study, the researchers are expanding on one of their previous findings - that vitamin C alone was able to kill cancer stem cells. Now, they’re testing whether this cancer-killing potential can be augmented with the addition of doxycycline, a common antibiotic.

Indeed, the team found that the vitamin C plus antibiotic combination was 100 times more effective at killing cancer stem cells than 2-DG, a drug under clinical trial to treat cancer. This is about 10 times more potent than treating the cancer cells with vitamin C alone.

The researchers hypothesize that the antibiotic stymied the cancer’s ability to switch fuels for energy. That is, without “metabolic flexibility,” as induced by the doxycycline, the cancer cells had to rely solely on glucose for survival. Then, they hypothesize that vitamin C acted as a “second punch,” and removed the source of glucose, which starved the cancer cells.

"In this scenario, vitamin C behaves as an inhibitor of glycolysis, which fuels energy production in mitochondria, the 'powerhouse' of the cell," said Dr. Federica Sotgia, a study co-author.

"This is further evidence that vitamin C and other non-toxic compounds may have a role to play in the fight against cancer," said Dr. Lisanti. "Our results indicate it is a promising agent for clinical trials, and as an add-on to more conventional therapies, to prevent tumor recurrence, further disease progression, and metastasis."

Additional source: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
MAY 11, 2021
Immunology
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
MAY 11, 2021
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
Researchers have discovered how a glitch in the brain’s immune system can inadvertently cause an accelerated growt ...
MAY 06, 2021
Cancer
What accounts for the disparities in mortality rates from kidney cancer?
MAY 06, 2021
What accounts for the disparities in mortality rates from kidney cancer?
New research published in the journal Cancers attempts to address gaps in data regarding mortality risk from advanced-st ...
MAY 27, 2021
Cancer
Which ovarian cancer patients will be resistant to platinum chemotherapy?
MAY 27, 2021
Which ovarian cancer patients will be resistant to platinum chemotherapy?
Research published in the journal EMBO Molecular Medicine details a novel mechanism that can be used to predict which ep ...
JUN 16, 2021
Cancer
New drug attacks pancreatic tumors with mutant KRAS addiction
JUN 16, 2021
New drug attacks pancreatic tumors with mutant KRAS addiction
Pancreatic cancer is notoriously difficult to detect in early stages, which is why it is associated with a low survival ...
JUN 23, 2021
Cancer
Military universal health system boasts higher survival rates for colon cancer patients
JUN 23, 2021
Military universal health system boasts higher survival rates for colon cancer patients
New results published in the American Association for Cancer Research journal Cancer Epidemiology, Biomarkers & Prev ...
Loading Comments...